Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer()

Accumulating evidence demonstrates important roles for histone deacetylase in tumorigenesis (HDACs), highlighting them as attractive targets for antitumor drug development. Histone deactylase inhibitors (HDACIs), which have shown favorable anti-tumor activity with low toxicity in clinical investigat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neoplasia
Main Authors: Zhang, Tao, Chen, Yihua, Li, Jingjie, Yang, Feifei, Wu, Haigang, Dai, Fujun, Hu, Meichun, Lu, Xiaoling, Peng, Yi, Liu, Mingyao, Zhao, Yongxiang, Yi, Zhengfang
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4234873/
https://ncbi.nlm.nih.gov/pubmed/25220594
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neo.2014.07.009
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados